What is Targeting Healthy Longevity?
The Kitalys Institute is organizing Targeting Healthy Longevity (previously Targeting Metabesity) for 2023 different from previous years, where the conference was a once a year event taking place over several days in October. For 2023, Targeting Healthy Longevity will consist of a series of free monthly conference session webinars, culminating in an in-person event near the end of the year.
The inaugural session, held on May 3, 2023, included a fireside chat with FDA Commissioner Rob Califf, addressing for the first time, to our knowledge, the regulation of healthspan products, followed by a roundtable discussion among healthy longevity leaders on regulatory challenges and opportunities.
Targeting Healthy Longevity Session 2 "Opportunities & Challenges Preempting Chronic Diseases Before They Start" took place on September 13, 2023. The extraordinary panel of Moderator George Vradenburg, Lord Ara Darzi, Hilary Evans, Mark McClellan, Dame June Raine and Samantha Roberts, spoke on the topic of interventions in the pre-disease state (e.g. Alzheimer’s vaccines) is key to healthy longevity; regulators and payers need to agree.
Session 3 of the Targeting Healty Longevity Series, "Loneliness: The Hidden Public Health Crisis", was attended by hundreds on October 17, 2023. Our speaker, Preeminent loneliness researcher, Julianne Holt-Lunstad, was interviewed during a fireside chat by co-moderators, Lucy Rose (founder of the Cost of Loneliness Project) and Jeremy Abbate (publisher of Scientific American).
Click HERE to view the recordings of first three sessions.
Our next webinar, Targeting Healthy Longevity Session 4, "A Roundtable Discussion on The COSMOS, COSMOS-Web and COSMOS Mind Trials", is scheduled for Friday, November 17, 2023 from 1 pm - 3 pm EST. To learn more about this event, the speakers and to register, click HERE.
Our audience cuts across sectors and disciplines for a multi-pronged approach to one of the most important health issues affecting people in all walks of life.
Healthcare - Administrators, clinicians, and patient advocates interested in the prevention and delay of illness and aging
Preclinical Research - Scientists involved in metabolic, cancer, dementia, cardiovascular and aging-related research
Clinical Research - Investigators and healthcare providers involved in chronic non-communicable disease care and prevention
Industry - Corporate leaders and startups that are developing pharmaceutical, digital health, nutrition, new business models and other approaches to disease prevention and healthy aging
Finance - Funders, payers and investors (including capital markets, philanthropies, government and insurers) in disease prevention and healthy aging
Policy and Law - Government regulators, policy makers, elected officials, and advisors involved in Healthspan equity and the future of Healthspan
Social Justice - Equity groups, social change agents, and philanthropic organizations interested in broadening access to healthy lifespan
Strategy - Futurists, epidemiologists, social scientists, economists, bioethicists, and others thinking about how to harness emerging science behind Metabesity for global public health
Academia - Instructors, administrators, students, and researchers across all fields of longevity, aging and Healthspan
Communications - Journalists and marketing professionals who recognize hot topics and emerging trends
The Interested Public
Inaugural Fireside Chat: FDA Commissioner on Healthy Longevity
Wednesday, May 3, 2023
Professor Medicine, university of Miami, Former President, ADA
President and Founder, Kitalys Institute
Targeting Healthy Longevity Session 2 "Opportunities & Challenges Preempting Chronic Diseases Before They Start"
Wednesday, September 13, 2023
Chairman & Co-Founder, UsAgainstAlzheimer’s, Moderator
Chief Executive of Alzheimer's Research UK
Mark Mcclellan, MD, PhD, MP
Former FDA Commissioner & Former CMS Administrator, Director, Duke Margolis Center
Dame June Raine
CEO of the Medicines and Healthcare Products Regulatory Agency, UK
The Right Honourable Lord Darzi of Denham
Chairman, Flagship Pioneering PMHI
Chair / Chief Executive Officer, Eli Lilly and Company
Dr. Samantha Roberts
Chief Executive Officer, National Institute for Health and Care Excellence, UK
Targeting Healthy Longevity Session 3 "Loneliness: The Hidden Public Health Crisis"
Tuesday, October 17, 2023
Founder of The Cost of Loneliness Project
Scientific Chair and Board Member, US Foundation for Social Connection and Global Initiative on Loneliness and Connection
Publisher of Scientific American
2023 Targeting Healthy Longevity Events
Previous Metabesity Conferences
The Targeting Metabesity 2022 conference took on one of the greatest healthcare challenges and opportunities of the 21st century: the prevention or delay of chronic diseases to achieve healthy longevity for all. This complex objective now appears achievable based on developments in geroscience in recent decades that suggest we may be able to delay, or even reverse, biological aging. This cross-disciplinary conference addresses the abundant opportunities for achieving equitable healthspan and the remaining challenges for converting discoveries into products for the general population.
The Targeting Metabesity 2021 conference will further take on one of the greatest healthcare challenges and opportunities of the 21st century: the prevention or delay of chronic diseases to achieve healthy longevity for all. This complex objective now appears achievable based on developments in geroscience in recent decades that suggest we may be able to delay, or even reverse, biological aging. Join us in October 11-14, 2021 both virtually and live in Washington, DC for an even more innovative and cross-disciplinary conference that addresses the abundant opportunities for achieving equitable healthspan and the remaining challenges for converting discoveries into products for the general population.
Targeting Metabesity 2020, held virtually due to the COVID-19 pandemic in October 2020, was broadcast live from Harpers Ferry, WV, and attracted about 1,000 registrants worldwide, with 80 speakers over four days. In addition to the usual stellar collection of scientists, doctors, and representatives of large and emerging companies and capital markets, speakers included the President of the National Academy of Medicine, the Scientific Director of the National Institute on Aging, the Director of the FDA Office of New Drugs, two members of Congress, a member of the U.K. House of Lords Chair of the U.K. All-Party Parliamentary Group for Longevity, Strategic Advisory Group, and several best-selling authors. Also, a new Day 4 was dedicated to an Emerging Company Showcase that featured corporate presentations by two dozen hot emerging 'metabolic' companies, with breakout sessions.
The second Metabesity conference, called by Margaretta Colangelo of Deep Knowledge Ventures "one of the most important longevity conferences of the year," was held in Washington, DC in 2019, with a stellar speakers roster that included Richard Hodes, Director of the National Institute on Aging, Gary Gibbons, Director of the National Heart, Lung and Blood Institute, Janet Woodcock, Director of the Center for Drug Evaluation and Research at FDA, Susan Mayne, Director of the Center for Food Safety and Applied Nutrition at FDA, and leaders from geroscience, diabetes, cancer, nutrition, exercise, large and emerging companies, connectivity and loneliness, longevity venture capitalists and other stakeholders.
Together with Professor Lawrence Steinman, former long-time head of the immunology department at Stanford and co-discoverer of the M.S. drug Tysabri, Dr. Fleming organized the inaugural Targeting Metabesity conference in London in 2017. This conference brought together what Alex Zhavoronkov, CEO of A.I. leader, Insilco Medicine, characterized in Forbes as a "staggering" set of speakers, including Oxford professors on the boards of Roche and the Novo Nordisk Foundation, Chair of the Nobel Assembly that selects the Nobel Prize for Medicine or Physiology, Deputy Chief Executive of UK NICE, CEO of the Buck Institute for Research on Aging, and CMO of the CMS under the Obama Administration.